Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Midgut carcinoid tumours. CT appearance

E Sugimoto1, L E Lörelius, B Eriksson

  • 1Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.

Acta Radiologica (Stockholm, Sweden : 1987)
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

ESMO open·2025
Same author

Learning from each other: Cross-cutting diagnostic development activities between magnetic and inertial confinement fusion (invited).

The Review of scientific instruments·2024
Same author

New method for time alignment and time calibration of the TOFOR time-of-flight neutron spectrometer at JET.

The Review of scientific instruments·2021
Same author

Histamine in gastric carcinoid tumors: Immunocytochemical evidence.

Endocrine pathology·2020
Same author

Electron-microscopical immunocytochemical study of a pancreatic islet amyloid polypeptidoma.

Endocrine pathology·2020
Same author

Antiserum directed against chromogranin A and B (CAB) is a useful marker for peptide hormone-producing endocrine cells and tumors.

Endocrine pathology·2020

Computed tomography (CT) aids in staging midgut carcinoid tumors by identifying metastases, though it struggles with primary tumor detection. It is valuable for assessing tumor spread and monitoring disease progression.

Area of Science:

  • Oncology
  • Radiology
  • Gastroenterology

Background:

  • Midgut carcinoid tumors are neuroendocrine neoplasms requiring accurate staging for effective treatment.
  • Computed tomography (CT) is a key imaging modality in oncological practice.

Purpose of the Study:

  • To evaluate the utility of CT in staging and follow-up of midgut carcinoid tumors.
  • To determine the sensitivity and specificity of CT in detecting primary tumors and metastases.

Main Methods:

  • Retrospective analysis of CT scans from 80 patients with histologically confirmed midgut carcinoid tumors.
  • Review of initial staging scans and follow-up examinations over a median of 3 years.
  • Correlation of imaging findings with biochemical markers (U-5-HIAA).

Related Experiment Videos

Main Results:

  • CT detected liver metastases in 68% of patients, mesenteric metastases in 21%, and retroperitoneal adenopathy in 24%.
  • In 21% of cases, CT was normal despite elevated U-5-HIAA, indicating limitations in detecting primary tumors.
  • Disease progression (new lesions) was identified in 39 patients during follow-up.

Conclusions:

  • CT is valuable for assessing the extent of carcinoid tumor spread and for monitoring disease progression.
  • CT has limited sensitivity for detecting primary midgut carcinoid tumors.
  • Combined with biochemical markers, CT plays a crucial role in the management of midgut carcinoid tumors.